These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy. Keyser DL; Rodnitzky RL Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810 [TBL] [Abstract][Full Text] [Related]
43. [Prevention and treatment of malignant syndrome in patients with Parkinson's disease]. Kuno S Nihon Rinsho; 2004 Sep; 62(9):1721-4. PubMed ID: 15462391 [TBL] [Abstract][Full Text] [Related]
44. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports]. Vetter P; Proppe D; Hoppe-Seyler S Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422 [No Abstract] [Full Text] [Related]
45. Neuroleptic malignant like syndrome in two patients on cholinesterase inhibitors. Grace JB; Thompson P Int J Geriatr Psychiatry; 2006 Feb; 21(2):193-4. PubMed ID: 16440373 [No Abstract] [Full Text] [Related]
47. Case study: cerebrovascular parkinsonism with levodopa addiction. Lily O; Al-Din A J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1365-6. PubMed ID: 15314141 [No Abstract] [Full Text] [Related]
48. Recurrent neuroleptic malignant syndrome due to haloperidol and amantadine. Hermesh H; Sirota P; Eviatar J Biol Psychiatry; 1989 Apr; 25(7):962-5. PubMed ID: 2720007 [No Abstract] [Full Text] [Related]
49. Psychotropic discontinuation symptoms: a case of withdrawal neuroleptic malignant syndrome. Stonecipher A; Galang R; Black J Gen Hosp Psychiatry; 2006; 28(6):541-3. PubMed ID: 17088172 [TBL] [Abstract][Full Text] [Related]
50. Neuroleptic malignant syndrome following levomepromazine discontinuation. Tanii H; Saka K; Inoue K; Okada M J Neuropsychiatry Clin Neurosci; 2010; 22(2):E16. PubMed ID: 20463130 [No Abstract] [Full Text] [Related]
51. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal. Tanii H; Fujita K; Okazaki Y Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884 [No Abstract] [Full Text] [Related]
52. [The neuroleptic malignant syndrome]. Duarte J; García Viejo MA; García Miguel FJ; Sempere AP Med Clin (Barc); 1994 Oct; 103(14):558. PubMed ID: 7799673 [No Abstract] [Full Text] [Related]
53. Intestinal pseudo-obstruction and neuroleptic malignant syndrome in a chronically constipated parkinsonian patient. Shimada J; Sakakibara R; Uchiyama T; Liu Z; Yamamoto T; Ito T; Mori M; Asahina M; Hattori T Eur J Neurol; 2006 Mar; 13(3):306-7. PubMed ID: 16618352 [No Abstract] [Full Text] [Related]
54. Parkinsonism-hyperpyrexia syndrome due to abrupt withdrawal of amantadine. Cheung YF; Hui CH; Chan JH Hong Kong Med J; 2011 Apr; 17(2):167-8. PubMed ID: 21471604 [No Abstract] [Full Text] [Related]
55. A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Takubo H; Harada T; Hashimoto T; Inaba Y; Kanazawa I; Kuno S; Mizuno Y; Mizuta E; Murata M; Nagatsu T; Nakamura S; Yanagisawa N; Narabayashi H Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S31-41. PubMed ID: 12735913 [TBL] [Abstract][Full Text] [Related]